BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients

Purpose BRCA1 and BRCA2 proteins are central to DNA repair process through homologous recombination. We hypothesize that BRCA1/BRCA2 mutation carriers may exhibit increased hematological toxicity when receiving genotoxic chemotherapy.